GlassScriptPhysician profile
Sohaib Aleem
NPI 1588894026
$4,209.00
in general payments reported to CMS, 2019-2025
19 companies · $1,582 in 2025
The $1,582 reported for 2025 was more than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2021: $525 · 2022: $895 · 2023: $171 · 2024: $925 · 2025: $1,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,645 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,645.11 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $967.28 | 2021-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $600.45 | 2019-2025 | Airsupra |
| Amgen INC. | $540.53 | 2022-2025 | Uplizna, Tezspire |
| Janssen Pharmaceuticals, INC | $498.44 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $299.91 | 2019-2025 | Dupixent |
| Abbott Laboratories | $258.17 | 2024 | Amplatzer Talisman, Mitraclip |
| Genzyme Corporation | $246.49 | 2025 | |
| Genentech USA, INC. | $235.30 | 2023-2025 | Xolair |
| Boston Scientific Corporation | $125.00 | 2024 | Watchman Flx |
| Ars Pharmaceuticals Operations, INC. | $102.41 | 2025 | Neffy |
| Novartis Pharmaceuticals Corporation | $89.47 | 2025 | |
| Alk-Abello, INC | $70.78 | 2022-2025 | |
| Abbvie INC. | $47.14 | 2022-2023 | Skyrizi |
| Csl Behring | $33.33 | 2025 | Hizentra |
| Aimmune Therapeutics, INC. | $29.71 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greer Laboratories, INC. | $28.36 | 2025 | Palforzia |
| Biocryst US Sales Co., LLC | $23.63 | 2022 | |
| Pfizer INC. | $12.60 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sohaib Aleem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.